Introduction

Hypertension is the most common of the cardiovascular diseases, which is theleading cause of morbidity and mortality in the industrial world as well as becoming an increasing common disease in the developing countries. Hypertension is a major risk factor for renal, cerebrovascular and cardiovascular diseases. Therefore it is the most pressing health problems in the world. Hypertension is called the “silent killer” because it often has no warning signs or symptoms¹. HTN is the most prevalent primary diagnosis reported in ambulatory care visits and its management accounts for 30% of office visits for individuals aged 45 to 65 years and more than 40% among those aged 64 and older². In contrast, controlled blood pressure levels are associated with higher probability of survival rate until age 85 years and also increased longevity without co-morbidities¹. However, despite advances in medical treatment and public campaigns to reduce the prevalence of hypertension, the disease remains a significant cause of health problems with huge health impacts mainly due to limited knowledge of risk factors related to the condition.

Another pandemic is Vitamin D insufficiency. Almost 50% of the world population is affected by Vitamin D insufficiency³. Vit D has known role in maintaining an adequate level of serum calcium, phosphorus, parathyroid hormone and normal bone metabolism alongwith there is evidence that Vit D has a biological effect more than mineral metabolism⁴. The majority of epidemiological studies have shown that Vit D deficiency is a major risk factor for arterial hypertension and cerebrovascular disease³.

1. Ostchega Y, Yoon S, Hughes J, & Louis T (2008). Hypertension awareness, treatment and control- continued disparities in adults: United States, 2005-2006. NCHS Data Brief, (3), 1-8. Retrived from http://www.cdc.gov/nchs/data/databriefs/db03.pdf
2. Cohen J.D (2009). Hypertension epidemiologyand economic burden: refining risk assessment to lower costs, Managed care, 51-57
3. Holick MF 2007.Vitamin D Deficiency. N Engl J Med 357:266-281
4. Zhang R, Naughton DP 2010. Vitamin D in health and disease current perspectives. Nutrition J9:65-78
5. Jorde R Svartberg J Sundsfjord J. Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men. J Hypertens 2005;23:1639–1644.
6. Snijder MB Lips P Seidell JC Visser M Deeg DJ Dekker JM van Dam RM. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med 2007;261:558–565.
7. Pilz S Tomaschitz A Ritz E Pieber TR Medscape. Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol2009;6:621–630.
8. Lee JH O'Keefe JH Bell D Hensrud DD Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?J Am Coll Cardiol 2008;52:1949–1956.
9. Artaza JN Mehrotra R Norris KC. Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol2009;4:1515–1522.
10. Forman JP Williams JS Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010;55:1283–1288.
11. Chen S Glenn DJ Ni W Grigsby CL Olsen K Nishimoto M Law CS Gardner DG. Expression of the vitamin d receptor is increased in the hypertrophic heart. Hypertension 2008;52:1106–1112.
12. Verhave G Siegert CE. Role of vitamin D in cardiovascular disease. Neth J Med 2010;68:113–118.
13. Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 2006; 147:5542–5548.
14. Prentice A Goldberg GR Schoenmakers I. Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr 2008; 88:500S–506
15. Holic MF. McMollum Award Lecture, 1994: Vitamin D- New Horizons for the 21^st Am J ClinNutr 1994; 60:619-30
16. Kochupillai N. Physiology of Vitamin D: Current Concepts. India J Med Res 2008; 127:256-62
17. Macdonal HM. Contributions of Sunlight and to Vitamin D status. Calcif Tissue Int 2013;92:163-76
18. Petelik M, Cross Hs. Vitamin D and Calcium insufficiency-related chronic disease: molecular and cellular pathophy-siology. Eur J ClinNutr 2009; 63: 1377-86.
19. Pilz S, Tomaschitz AC, Zittermann A, Decker JM, Marz W. Vitamin D supplementation: A promising approach for the prevention and treatment of strokes. Curr Drug Targets 2010; 88-96
20. Judd SE, Raiser SN, Kumari M et al 1,25 dihydroxy Vitamin D3 reduces systolic blood pressure in Hypertensive adults: A pilot feasibility study. The Journal of steroid biochemistry and molecular biology 121(1-2), 445-447, 2010
21. Li YC, Kong J et al. 1,25-Dihydroxyvitamin D₃is a negative endocrine regulator of the renin-angiotensin system. The Journal of clinical investigation 110 (2), 229-238, 2002
22. MacGregor GA, Cappuccio FP. The kidney an essential hypertension :a link to osteoporosis? Journal of Hypertension; 11(8) 781-85: 1993
23. Gagan Velayudhan, Sasidharan PK. Vitamin D status in hypertension AIJRFANS 14-41 ;2014
24. SP Jamshoro, S Pakistan. Vitamin D deficiency in patients with essential hypertension .ejpmr,2016; 3(11) 225-228
25. JS Adams. Update in vitamin D. The Journal of clinical Endocrinology & Metabolism 95(2), 471-478, 2010
26. Fatehmeh Ardeshir Larijanietal. The relation between serum Vitamin D levels and Blood pressure: A population based study Acta Medica Iranica; vol 52 no4 290-296 2014

Dr Shivani Bansal

III-E, 99 Nehru Nagar, Ghaziabad, U.P., India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Mobile number 9013451039, landline number 0120-279611